SkyAI Announces Tender Offer to Buy Back Shares and Warrants
SkyAI, Inc. has initiated a tender offer to repurchase up to 95% of its outstanding shares and warrants at $3.00 each, signaling a strategic shift.
Veradermics Reports Positive Phase 3 Trial Results for VDPHL01
Veradermics, Inc. announced positive Phase 3 trial results for VDPHL01, a treatment for hair loss, potentially reshaping the pharmaceutical market.
Cardinal Infrastructure Group announces merger with HBC
Cardinal Infrastructure Group Inc. has entered into a merger agreement with Hughes Brothers Construction Inc., signaling growth in the heavy construction sector.
OS Therapies launches warrant exercise inducement offer
OS Therapies Inc has launched a warrant exercise inducement offer to raise funds for clinical trials and regulatory activities.
BioCardia Announces FDA Acceptance of Helix Catheter Submission
BioCardia, Inc. announces FDA acceptance of its Helix catheter pre-submission package, signaling potential growth in the biological products market.
Silence Therapeutics to Be Acquired by Merck KGaA for $6.67/Share
Silence Therapeutics plc has agreed to be acquired by Merck KGaA for $6.67 per share, marking a significant move in the pharmaceutical preparations sector.
Tron Inc. Elected as Super Representative on TRON Network
Tron Inc. elected as Super Representative on TRON network, expanding its digital asset strategy and blockchain governance role.
LQR House Secures $3 Million AI Computing Agreement
LQR House Inc. announces a $3 million agreement for AI computing resources to enhance its subsidiary's analytics and research capabilities.
Williams-Sonoma Appoints Lynn Martin to Board of Directors
Williams-Sonoma, Inc. announces the appointment of Lynn Martin to its Board of Directors, effective October 19, 2026, enhancing its leadership team.
Dogwood Therapeutics secures $5 million in private placement
Dogwood Therapeutics raises $5 million through a private placement with Sealbond Limited, enhancing its capital for future growth.
ArriVent BioPharma Announces Phase 1b Results for Firmonertinib
ArriVent BioPharma reveals promising Phase 1b results for firmonertinib, targeting EGFR PACC-mutant non-small cell lung cancer.
MKS Inc. sells Ophir Optics business to TTM Technologies for $650M
MKS Inc. has entered a definitive agreement to sell its Ophir Optics business to TTM Technologies for $650 million, expected to close in Q2 2027.
DeFi Development Corp. Reports Growth in Solana Holdings
DeFi Development Corp. announces a significant increase in Solana holdings ahead of the Alpenglow upgrade, enhancing its position in the finance services sector.
Expand Energy Corp appoints Daniel E. Brown as CEO
Expand Energy Corp has appointed Daniel E. Brown as CEO, effective October 26, 2026, aiming to enhance its strategic direction in the energy sector.
Eos Energy Reports Strong Q3 2026 Results, Revenue Growth
Eos Energy Enterprises announces preliminary Q3 2026 results with revenue growth of up to $83 million and improvements in gross margin.
H.B. Fuller Rejects Ancora's Acquisition Proposal, Plans Market Check
H.B. Fuller Company rejects Ancora Holdings' acquisition bid for its Building Adhesive Solutions segment and plans a market check for select segments.
CorMedix Announces FDA Acceptance for REZZAYO sNDA
CorMedix Inc. announces FDA acceptance of its sNDA for REZZAYO, targeting invasive fungal diseases, with promotional efforts planned for late 2027.
Agassi Sports Entertainment converts $1M note into equity
Agassi Sports Entertainment Corp. converts a $1 million promissory note into equity, strengthening its financial position in the retail-miscellaneous sector.
Clene Inc. submits NDA for ALS treatment CNM-Au8
Clene Inc. has submitted a New Drug Application to the FDA for CNM-Au8, a potential treatment for ALS, marking a key milestone for the company.
Teamshares Inc. secures $130 million term loan to refinance debt
Teamshares Inc. has secured a $130 million term loan to refinance existing debt, signaling a strategic shift in the retail sector.